22 completed, 7 terminated, 6 withdrawn, 5 unknown. 13 Phase 3, 11 Phase 4, 10 Phase 2, 7 Not applicable, 4 Phase 1.
Follow iron sucrose: new trials by email Literature Review of iron sucrose trials Research Report on iron sucrose
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| COMPARISON OF EFFICACY OF ORAL VS IV IRON THERAPY IN CHILDREN AGED 12-59 MONTHS, WITH IRON DEFICIENCY ANEMIA Oral ferrous sulfate, iron sucrose - Iron Deficiency Anemia in Children | Phase 2 | Not yet recruiting | Kharadar General Hospital | 100 | 2027-01-01 | 2026-06-18 |
| Iron Administration Via Colonic TET Combined With WMT for ID Ferrous Lactate, Iron sucrose, 0.9% NaCl solution - Iron Deficiency Anemia in Childbirth | Phase 2 | Unknown | The Second Hospital of Nanjing Medical University | 60 | 2024-07-25 | 2024-07-22 |
| Intravenous Iron Versus Oral Iron for the Treatment of Iron Deficiency Anemia Venofer 200 MG Per 10 ML Injection, Ferrous sulfate - Iron Deficiency Anemia of Pregnancy | Phase 3 | Unknown | Arrowhead Regional Medical Center | 900 | 2023-11-21 | 2024-04-16 |
| Iron Therpay and Fatigue in Women of Reprodcutive Age Iron sucrose, Placebo - Fatigue Syndrome, Chronic, Fatigue | Not applicable | Completed | Central Park Medical College | 194 | 2023-02-25 | 2024-09-19 |
| Ferric Derisomaltose (Iron Isomaltoside) Versus Iron Sucrose for Treatment of Iron Deficiency in Pregnancy Iron Isomaltoside 1000, ferric derisomaltose, Iron sucrose - Iron Deficiency Anaemia in Childbirth | Phase 3 | Recruiting | Saskatchewan Health Authority - Regina Area | 280 | 2022-06-06 | 2025-05-15 |
| A Study to Evaluate Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects ferumoxytol, Iron sucrose - Iron Deficiency Anemia | Phase 3 | Recruiting | AMAG Pharmaceuticals, Inc. | 75 | 2019-09-18 | 2026-04-17 |
| Evaluation and Treatment of Iron Deficiency in Ovarian Cancer Patients Iron Sucrose - Epithelial Ovarian Cancer, Anemia | Phase 1 / Phase 2 | Terminated | University of Wisconsin, Madison | 9 | 2019-07-29 | 2023-01-05 |
| Hemoglobin Optimization to Prevent Transfusion and Adverse Events in Perioperative Patients With Iron Restricted Anemia Iron sucrose, Epoetin Alfa, Placebo - Anemia, Iron Deficiency, Anemia of Chronic Disease | Phase 2 | Terminated | Unity Health Toronto | 4 | 2019-07-01 | 2021-06-18 |
| Erythropoietin And/Or Iron Sucrose For Perioperative Anemia Management In Hip and Knee Arthroplasty rHuEPO, Iron sucrose - Anemia, Iron Deficiency | Unknown | Peking Union Medical College Hospital | 780 | 2019-04-24 | 2019-04-25 | |
| Iron Isomaltoside Compared With Iron Sucrosein Peritoneal Dialysis Patients Iron Isomaltoside, Iron sucrose - Iron Deficiency Anemia Treatment | Not applicable | Terminated | The University of Hong Kong | 16 | 2019-02-01 | 2021-10-06 |
| Artificial Intelligence for Optimal Anemia Management in End-stage Renal Disease: The Anemia Control Model (ACM) Trial Anemia Control Model (ACM), IV iron, Erythropoiesis-Stimulating Agent (ESA) - Anemia, End Stage Renal Disease | Not applicable | Terminated | Vifor Fresenius Medical Care Renal Pharma | 88 | 2018-12-10 | 2020-01-07 |
| A Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects With Chronic Kidney Disease (CKD) Ferumoxytol, Iron sucrose - Chronic Kidney Disease; Iron Deficiency Anemia | Phase 3 | Recruiting | AMAG Pharmaceuticals, Inc. | 129 | 2018-08-13 | 2026-04-17 |
| To Assess the Impact of Ferric Carboxymaltose Compared With Iron Sucrose in Chinese Subjects on Correcting Iron Deficiency Anaemia Ferric carboxymaltose, Iron sucrose - Iron Deficiency Anemia | Phase 3 | Completed | Vifor (International) Inc. | 371 | 2017-07-03 | 2021-06-10 |
| Randomized Study Comparing Ferric Carboxymaltose to Iron Sucrose to Treat Fe Deficiency in the Surgically Critically Ill Ferric carboxymaltose, Iron sucrose - ICU Anemia, Functional Iron Deficiency | Phase 1 | Withdrawn | Denver Health and Hospital Authority | 2017-02-01 | 2018-01-12 | |
| The Safety of a High-Dose, Rapid Infusion of Iron Sucrose Iron sucrose - Iron Deficiency | Phase 2 | Withdrawn | The Guthrie Clinic | 2017-01-01 | 2017-10-18 | |
| Iron Isomaltoside/Ferric Derisomaltose vs Iron Sucrose for Treatment of Iron Deficiency Anemia in Non-Dialysis-Dependent Chronic Kidney Disease Iron isomaltoside/ferric derisomaltose, Iron sucrose - Iron Deficiency Anaemia, Iron Deficiency Anemia | Phase 3 | Completed | Pharmacosmos A/S | 1538 | 2016-11-29 | 2020-10-06 |
| Iron Isomaltoside/Ferric Derisomaltose vs Iron Sucrose for the Treatment of Iron Deficiency Anemia (IDA) Iron isomaltoside/ferric derisomaltose, Iron sucrose - Iron Deficiency Anaemia, Iron Deficiency Anemia | Phase 3 | Completed | Pharmacosmos A/S | 1512 | 2016-11-08 | 2020-10-06 |
| Iron Deficiency and FGF23 Regulation in CKD and HF Iron Sucrose - Chronic Kidney Diseases, Chronic Heart Failure | Completed | Northwestern University | 77 | 2015-12-18 | 2019-03-20 | |
| Treatment Response in Dialysis Anaemia Iron sucrose, Erythopoietin stimulating agent - Anaemia, Haemodialysis | Phase 4 | Completed | Imperial College Healthcare NHS Trust | 197 | 2015-07-01 | 2021-04-14 |
| RCT of Goal-directed Iron Supplementation of Anemic, Critically Ill Trauma Patients, With and Without Oxandrolone Iron sucrose, Oxandrolone, IV iron placebo - Functional Iron Deficiency, Trauma | Phase 2 | Withdrawn | Denver Health and Hospital Authority | 2015-01-01 | 2019-04-03 |
Showing 20 of 46. Sign in to see all of them.
Anemia (19) · Anemia, Iron-Deficiency (16) · Iron Deficiencies (10) · Renal Insufficiency, Chronic (9) · Altitude Sickness (2) · Colitis, Ulcerative (2) · Crohn Disease (2) · Hypertension, Pulmonary (2) · Hypoxia (2) · Inflammatory Bowel Diseases (2) · Kidney Failure, Chronic (2) · Wounds and Injuries (2) · Carcinoma, Ovarian Epithelial (1) · Critical Illness (1) · Endotoxemia (1)
AMAG Pharmaceuticals, Inc. (5) · American Regent, Inc. (3) · Denver Health and Hospital Authority (3) · Pharmacosmos A/S (3) · Hospital Clinic of Barcelona (2) · University of Oxford (2) · Anemia Working Group Romania (1) · Arrowhead Regional Medical Center (1) · Assiut University (1) · Central Park Medical College (1) · Duke University (1) · Hospira, now a wholly owned subsidiary of Pfizer (1) · Hospital Aleman (1) · Imperial College Healthcare NHS Trust (1) · Kharadar General Hospital (1)
United States (18) · Canada (6) · United Kingdom (5) · Poland (4) · China (3) · Germany (3) · Lithuania (3) · Spain (3) · Australia (2) · Hungary (2) · India (2) · Pakistan (2) · Romania (2) · Argentina (1) · Austria (1)
Fredric M Pieracci, MD, MPH (3) · Amie Jones, MD (1) · Andrew Artz, MD (1) · Bradley Lash, MD (1) · Carol Duffy, D.O.,FACC (1) · Christoph Gasche, Professor (1) · Cyrus C Hsia, MD,FRCPC (1) · Damien Dr Ashby, MBBS (1) · Efstathios Mitsopoulos, MD (1) · Elizabeth Price, MD (1) · Faming Faming, PhD (1) · Fiona E Ralley, MB ChB, FRCA (1) · Gabriel Mircescu, Professor (1) · Gregory MT Hare, MD PhD (1)
PMID 19406557, PMID 19809026, PMID 24458078, PMID 24797376, PMID 26848182, PMID 26971581, PMID 28372549, PMID 30121943, PMID 30802204, PMID 31243803, PMID 31413088, PMID 31811820, PMID 32049331, PMID 32053933, PMID 34839481, PMID 35113024, PMID 36107229
2009 (1), U01AG034661 (1)